MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC
|
disease |
|
Disease or Syndrome
|
2
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Visual symptoms
|
phenotype |
|
Sign or Symptom
|
17
|
5
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Myelitis
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
22
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Diffuse alveolar damage
|
disease |
|
Disease or Syndrome
|
22
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Color blindness
|
disease |
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
33
|
4
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Chemical Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
71
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Optic Neuritis
|
disease |
Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
79
|
4
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Hidradenitis Suppurativa
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
82
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Phenylketonurias
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
83
|
46
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Color vision defect
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
94
|
4
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Advanced breast cancer
|
disease |
|
Neoplastic Process
|
151
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neuromyelitis Optica
|
disease |
Eye Diseases; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
171
|
45
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Atrial Premature Complexes
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
183
|
21
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Drug habituation
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
196
|
19
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Skin Erosion
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
225
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2009 |
2009 |
bone destruction
|
disease |
|
Disease or Syndrome
|
234
|
3
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Superficial ulcer
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
242
|
10
|
0.010 |
None |
< 0.001 |
1 |
|
2009 |
2009 |
Clear-cell metastatic renal cell carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
260
|
11
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
precancerous lesions
|
phenotype |
|
Neoplastic Process
|
270
|
19
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Bone Diseases
|
group |
Musculoskeletal Diseases
|
Disease or Syndrome
|
317
|
10
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Headache
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
338
|
75
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Lymphoma, T-Cell, Cutaneous
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
367
|
5
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Glaucoma, Primary Open Angle
|
disease |
Eye Diseases
|
Disease or Syndrome
|
383
|
222
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |